BioSimulytics develops AI-powered software for drug researchers.
BioSimulytics has raised €600k across 1 funding round from 2 investors, most recently a Seed round in Sep 2021. Based in Dublin, Ireland; active in Software and AI. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-09-03 | Seed | €600k |
| Angel Investors,Enterprise Ireland |
| View deal → |
